Clinical Trials Browser

Phase 2 × ilorasertib × Tumor-Agnostic × Clear all

NCT02478320 2023-07-17

Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors

Phase 2 Terminated

12 enrolled 11 charts

Neoplasm Metastasis